Healthcare provider profile · identity verified

Eric S Haskell, DO

Internal Medicine · CAPE ELIZABETH, ME · NPI 1770742439

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	614	180
Lisinopril	Lisinopril	385	117
Levothyroxine Sodium	Levothyroxine Sodium	338	86
Amlodipine Besylate	Amlodipine Besylate	326	96
Omeprazole	Omeprazole	235	70
Losartan Potassium	Losartan Potassium	183	52
Rosuvastatin Calcium	Rosuvastatin Calcium	161	44
Metoprolol Succinate	Metoprolol Succinate	151	48
Hydrochlorothiazide	Hydrochlorothiazide	149	47
Simvastatin	Simvastatin	145	45
Sertraline Hcl	Sertraline Hcl	142	39
Gabapentin	Gabapentin	138	47
Tamsulosin Hcl	Tamsulosin Hcl	126	41
Eliquis	Apixaban	114	39
Trazodone Hcl	Trazodone Hcl	109	35
Albuterol Sulfate Hfa	Albuterol Sulfate	101	41
Oxycodone Hcl	Oxycodone Hcl	87	22
Metformin Hcl Er	Metformin Hcl	82	22
Metoprolol Tartrate	Metoprolol Tartrate	81	24
Lorazepam	Lorazepam	80	29
Allopurinol	Allopurinol	73	21
Atenolol	Atenolol	71	21
Bupropion Xl	Bupropion Hcl	71	22
Clonazepam	Clonazepam	71	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	15
Furosemide	Furosemide	70	24
Mirtazapine	Mirtazapine	70	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	69	24
Metformin Hcl	Metformin Hcl	68	23
Duloxetine Hcl	Duloxetine Hcl	63	15
Escitalopram Oxalate	Escitalopram Oxalate	61	19
Pravastatin Sodium	Pravastatin Sodium	61	21
Citalopram Hbr	Citalopram Hydrobromide	59	16
Fluoxetine Hcl	Fluoxetine Hcl	57	18
Potassium Chloride	Potassium Chloride	57	11
Ozempic	Semaglutide	56	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	12
Zolpidem Tartrate	Zolpidem Tartrate	55	23
Prednisone	Prednisone	54	33
Alendronate Sodium	Alendronate Sodium	52	17
Ezetimibe	Ezetimibe	49	12
Pregabalin	Pregabalin	49	13
Alprazolam	Alprazolam	47	13
Tramadol Hcl	Tramadol Hcl	47	16
Pantoprazole Sodium	Pantoprazole Sodium	43	16
Famotidine	Famotidine	42	15
Labetalol Hcl	Labetalol Hcl	41	suppressed
Jardiance	Empagliflozin	38	suppressed
Carvedilol	Carvedilol	37	suppressed
Chlorthalidone	Chlorthalidone	37	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	12
Xarelto	Rivaroxaban	37	12
Finasteride	Finasteride	35	11
Fluticasone Propionate	Fluticasone Propionate	35	17
Montelukast Sodium	Montelukast Sodium	35	12
Mounjaro	Tirzepatide	35	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	33	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	31	14
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Meloxicam	Meloxicam	25	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Estradiol	Estradiol	21	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Baclofen	Baclofen	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Temazepam	Temazepam	19	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	13
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	15
Colchicine	Colchicine	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Sumatriptan	Sumatriptan	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Rizatriptan	Rizatriptan Benzoate	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Diazepam	Diazepam	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	14	11
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Valsartan	Valsartan	14	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	14	suppressed
Belbuca	Buprenorphine Hcl	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Methylphenidate Er	Methylphenidate Hcl	13	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	11	suppressed
Glipizide	Glipizide	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error